Details for Patent: 10,774,091
✉ Email this page to a colleague
Which drugs does patent 10,774,091 protect, and when does it expire?
Patent 10,774,091 protects LYNKUET and is included in one NDA.
This patent has forty-one patent family members in thirty-five countries.
Summary for Patent: 10,774,091
| Title: | Soft gelatin capsule formulation |
| Abstract: | The present invention generally relates to novel pharmaceutical formulations containing 2-[3,5-Bis(trifluoromethyl)phenyl]-N-{4-(4-fluoro-2-methylphenyl)-6-[(7S,9aS)-7-(hydroxymethyl)hexahydropyrazino[2,1-c][1,4]oxazin-8(1H)-yl]-3-pyridinyl}-N,2-dimethylpropanamide, methods of preparation thereof and their use in medical therapy. |
| Inventor(s): | Mike Trower, Monica Lazaro, Derek BUSH, David Elder, Mary Kerr |
| Assignee: | Kandy Therapeutics Ltd |
| Application Number: | US16/351,659 |
|
Patent Claim Types: see list of patent claims | Use; Formulation; Dosage form; |
| Patent landscape, scope, and claims: |
More… ↓ |
Drugs Protected by US Patent 10,774,091
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bayer Hlthcare | LYNKUET | elinzanetant | CAPSULE;ORAL | 219469-001 | Oct 24, 2025 | RX | Yes | Yes | 10,774,091 | ⤷ Start Trial | Y | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 10,774,091
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2019233606 | ⤷ Start Trial | |||
| Brazil | 112020017388 | ⤷ Start Trial | |||
| Canada | 3092238 | ⤷ Start Trial | |||
| Chile | 2020002350 | ⤷ Start Trial | |||
| China | 112292132 | ⤷ Start Trial | |||
| China | 119950513 | ⤷ Start Trial | |||
| Colombia | 2020011262 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
